Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2025 Earnings Call Transcript February 23, 2026
Axsome Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.71 EPS, expectations were $-0.7.
Operator: Good morning and welcome to the Axsome Therapeutics, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. My name is Kevin, and I will be your operator for today’s call. At this time, participants are in a listen-only mode. Later, there will be a question-and-answer...
